In The News Posted November 16, 2021 Share Posted November 16, 2021 SK bioscience presenta la solicitud de licencia biológica (BLA) para NVX-CoV2373, la primera candidata a vacuna contra la COVID-19 basada en proteínas, al Ministerio de Seguridad Alimentaria y Farmacéutica (MFDS) de Corea del Sur GAITHERSBURG, Maryland, 15 de noviembre de 2021...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.